Washington Post October 17, 2019
The jury in the landmark trial, which starts Oct. 21, will decide whether drug companies should be held responsible for the worst drug crisis in U.S. history.
As a landmark trial begins over who should pay for the nation’s opioid crisis, a new report estimates the epidemic has cost the U.S. economy at least $631 billion — and that more than two-thirds of that toll fell on individuals and the private sector.
A study released this week by the Society of Actuaries identified which parts of the economy have suffered the most from one of this century’s worst public health crises. The actuaries found that the epidemic’s biggest costs stemmed from the unrealized earnings of those killed by the...
Today's Sponsors
Today's Sponsor